The newly appointed managing director for pharma company MSD in Vietnam has reflected on the company’s decades-long presence ...

Bristol-Myers Squibb's stock is set to rise with FDA approvals, acquisitions, and a strong oncology portfolio, despite ...

Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

Kiran Mazumdar-Shaw accompanied her niece in ringing the opening bell at the Nasdaq headquarters in New York City, marking a ...

Moreno’s campaign website features a page titled “Key Messaging Against Sherrod Brown.” It claims Brown voted to give Social ...

Moses has backed other bills aimed at cutting safety net programs. In 2022, he introduced a bill to deny Medicaid to any ...

JNJ files for voluntary bankruptcy for the third time. Pfizer withdraws sickle-cell drug drug Oxbryta from worldwide markets.

Awardees were recognized for developing renewable lubricant base oils and ethyl acetate, more environmentally-friendly ...

Shares of Merck (NYSE:MRK) traded marginally higher on Friday after falling from a high of $119.38 from the past seven ...

The agency is considering whether to limit the indications of Keytruda, Opdivo, and Tevimbra to PD-L1-positive patients amid testing uncertainties.

The global calcium oxide market share is witnessing substantial growth, with a valuation of USD 4,573.4 Million in 2022, and ...

Beyond acquisitions, we continue to expect steady future dividends, supported by a payout ratio of close to 50% relative to adjusted earnings per share. Patents, economies of scale, and a powerful ...